Status: Recruiting
DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma
The purpose of this study is to determine the feasibility of administering DL-alpha-difluoromethylornithine (DFMO) to patients with relapsed Ewing sarcoma and osteosarcoma who have completed all planned therapy and have no evidence of disease.
Participants needed: 15
Trial details
Phase: Phase 1, Phase 2Age: Up to 39Biological sex: AllType: InterventionalSponsor: Montefiore Medical CenterUpdated: May 14, 2026Locations: 1
Eligibility criteria
Patients < 40 years of age at the time of enrollment [+11]
Pregnant or breastfeeding females. Men and women of childbearing potential and t... [+2]